TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE: OGEN), a leader in the development of novel, effective antibiotics and oral care probiotics, today announced two new appointments to the Product Development team. Joining the company are Guojun (Shawn) Nie Ph.D., as Director of Process Development, and Mr. Joel Ngoje as Senior Process Scientist. Together, the two bring almost 40 years of pharmaceutical, protein and process development experience to the company. Encouraging progress from the development of Oragenics’ novel Lantibiotic platform has necessitated the accelerated expansion of the R & D team to position the pipeline for clinical success.
Help employers find you! Check out all the jobs and post your resume.
